Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
about
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent triosVariation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatmentAssociation of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adultsThe dynamic epigenome and its implications for behavioral interventions: a role for epigenetics to inform disorder prevention and health promotionLinking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric DisordersSteroid Receptor-Associated Immunophilins: A Gateway to Steroid SignallingMolecular and genetic basis of depressionFKBP51 and FKBP52 in signaling and diseaseStress physiology and developmental psychopathology: past, present, and future.Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperonesFrom the neurobiology of extinction to improved clinical treatments.From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentBiomarkers predicting antidepressant treatment response: how can we advance the field?Stress and the HPA axis: role of glucocorticoids in alcohol dependence.Schizophrenia in the spectrum of gene-stress interactions: the FKBP5 exampleGenetic Approaches to Hypothalamic-Pituitary-Adrenal Axis RegulationGlucocorticoids, epigenetic control and stress resilienceTreatment-resistant depression: critique of current approachesNew approaches to antidepressant drug discovery: beyond monoaminesTen years of Nature Reviews Neuroscience: insights from the highly citedThe Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety DisordersA new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51.Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performanceAssociation of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humansProteomic analysis of rat hippocampus exposed to the antidepressant paroxetineGenetic Moderation of Stress Effects on Corticolimbic CircuitryExpression and regulation of the Fkbp5 gene in the adult mouse brainGenomewide association scan of suicidal thoughts and behaviour in major depressionEffects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disordersStress and the brain: from adaptation to diseaseProgress and prospects in pharmacogenetics of antidepressant drugs.Western High-Fat Diet Consumption during Adolescence Increases Susceptibility to Traumatic Stress while Selectively Disrupting Hippocampal and Ventricular VolumesDissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.Biomarkers in posttraumatic stress disorder: overview and implications for future researchThe CRF system, stress, depression and anxiety-insights from human genetic studies.A single gene defect causing claustrophobiaHDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.Genetics of emotion.Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide.
P2860
Q24538580-B54CAAB5-3C6E-45D3-A170-D42936256A36Q24546379-EA84B602-FBB7-4BDF-B226-3D47FF30A0A3Q24649595-21029650-1232-4F31-9C1E-A233C67DEA76Q26751394-AD27C414-EF61-4376-BF4B-4EF04FFFE09FQ26765236-23596826-DA6A-4C2B-B3F2-A053488A94BEQ26801686-54306670-1046-4D6F-B491-65CD53A157EEQ26827615-A89EF994-5198-4EB3-8109-C328E2B53383Q26861304-AF8D2D79-78BF-4231-A116-F951A361E0ABQ26997176-0E22B0ED-3DD0-4DDD-A76F-B0DA50FE3A7FQ27011776-C2918DD8-0902-4F42-8A93-0F141D2C9676Q27011901-2596F507-4649-4276-A407-D492CFB79D73Q27015830-7A9F6306-5391-4435-A44F-36E8B99AF605Q27026147-DEEFB0C2-9B09-4EB9-BABC-A1CE748C5E19Q27693315-0BB32BBD-F853-4ECB-9B04-68B69B615780Q28081381-BF050FA3-2C19-498B-A84B-9C4356558793Q28082581-DD9009C3-FBBD-46C8-8B41-DB64A92C6DC8Q28088692-A3AC5583-AE00-4E94-9CBE-5895B16CD255Q28290605-293008EE-BB54-4D8B-BAC9-0A97A24414B7Q28293089-0D22F23A-B805-4C0B-BBBD-DAC02C23CA76Q28386297-CCB2D0F1-3916-4A9C-B198-AB8DC35B807FQ28396166-8651C569-48B4-4F73-94F4-AF5BE2A91F71Q28477103-04DA48EC-7B92-4370-9F32-51B4BD40F872Q28541339-88D74E0E-01D1-4889-A94F-73B7190E4A5CQ28544844-296AD422-4D4B-4999-AE3F-6B80BB1809B3Q28567997-E5CB59A6-2410-43AD-B6C7-8A05CC2E1CAFQ28606435-BC7AC47E-7CB6-4EE4-B6BF-54A24E20B390Q28742919-23086C1E-148E-4BFD-B7F9-E5F5018F2E00Q28742939-50FB4670-60C2-45D3-8AC6-EBCACE40459FQ28822036-AF3F82C1-E1B6-46BA-85C8-6C8F8B58156EQ29619381-4590D3FA-8C87-438F-B98E-E6559132BADCQ30249569-36E38701-E89A-4402-BF78-11DEC495F7A9Q30370012-1CE4F673-93B5-473A-BC66-CCE919808CE7Q30394714-2B47A4E1-85F4-4F29-86FE-479F50229361Q30433255-6259C7CB-F346-439E-B883-5B966B737246Q30448609-6F7D41B6-DEB8-4113-BA25-0E44496FF674Q30454302-5209998A-995D-4BD5-B01B-6FD117F3F50BQ30454903-477C4AA6-D9DC-435C-9ABA-620CBC570284Q30463355-3865B7D0-431C-4AE8-90E1-2D3ABB33116AQ30464322-C2AB10C9-8AC4-4464-9971-0B3872E005B8Q30477930-E03AF734-F50F-44A7-914A-CD70E721934F
P2860
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@ast
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@en
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@nl
type
label
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@ast
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@en
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@nl
prefLabel
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@ast
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@en
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Polymorphisms in FKBP5 are ass ...... se to antidepressant treatment
@en
P2093
Andrea Pfennig
Brigitta Bondy
Brigitte Fuchs
Elin Lõhmussaar
Elisabeth B Binder
Gabriele M Wochnik
Heike Dabitz
Heike E Künzel
Hildegard Pfister
Jakob C Mueller
P2860
P2888
P304
P3181
P356
10.1038/NG1479
P407
P50
P577
2004-12-01T00:00:00Z